Medical Condition News

RSS

Taking antiepileptic drug valproate during pregnancy affects the IQ of children

Research published in The Lancet Neurology shows that taking the antiepileptic drug valproate during pregnancy affects the IQ of children up to the age of six.

23 Jan 2013

SOPHIE project to evaluate social and economic policies’ impact on health inequalities

Europe will assess the impact of social and economic policies on health inequalities through the SOPHIE project. Health inequalities are avoidable and unfair differences determined by the circumstances in which people of different social groups are born, live, work and age.

23 Jan 2013

Amgen drug gets boost in fiscal cliff legislation

Just two weeks after pleading guilty in a major federal fraud case, Amgen, the world's largest biotechnology firm, scored a largely unnoticed coup on Capitol Hill: Lawmakers inserted a paragraph into the "fiscal cliff" bill that did not mention the company by name but strongly favored one of its drugs.

23 Jan 2013

SMO and AKT1 mutations appear to drive about 15% of meningiomas

Large-scale genomic sequencing has revealed two DNA mutations that appear to drive about 15 percent of brain tumors known as meningiomas, a finding that could lead to the first effective drug treatments for the tumors, report scientists from Dana-Farber Cancer Institute and the Broad Institute.

23 Jan 2013

Tumor separation surgery followed by SRS is safe and effective in controlling spinal metastases

Researchers from Memorial Sloan-Kettering Cancer Center (New York, NY) have found that tumor "separation surgery" followed by high-dose hypofractionated stereotactic radiosurgery (SRS) or high-dose single-fraction SRS is safe and effective in controlling spinal metastases regardless of the radiosensitivity of the particular tumor type that has invaded the spine.

23 Jan 2013

Trial to evaluate whether zolpidem reduces suicidal thinking in depressed insomniacs

Researchers want to know whether a sleeping pill reduces suicidal thoughts in depressed patients with insomnia.

23 Jan 2013

GORE DrySeal Sheath with hydrophilic coating now available in Europe

W. L. Gore & Associates (Gore) today introduced GORE DrySeal Sheath with hydrophilic coating in Europe. The new GORE DrySeal Sheath allows for easier insertion into and removal from blood vessels during endovascular repair procedures.

23 Jan 2013

HBR Lab offers free treatment for individuals with both weight and chronic pain

To combat ever-increasing rates of obesity in the U.S. and to reduce suffering from the pain that can occur with increased weight, the Health Behavior Research Lab (HBR) at University of the Sciences is offering free treatment for individuals struggling with both weight and chronic pain.

23 Jan 2013

GeneDiagnostics, WILEX partner to commercialize serum HER-2/neu ELISA test in China

WILEX AG today announced that its US subsidiary WILEX Inc., Cambridge, MA, has entered into an exclusive distribution agreement with GeneDiagnostics Inc. for the commercialization of the serum HER-2/neu ELISA test in China.

23 Jan 2013

Covidien’s EverFlex stent with Entrust delivery system receives CE Mark

Covidien, a leading global provider of healthcare products, today announced CE Mark approval for its EverFlex Self-expanding Peripheral Stent with Entrust Delivery System.

23 Jan 2013

Study finds 70% increase in type 1 diabetes among very young Philadelphian children

Over the past two decades, the incidence of type 1 diabetes in very young children under age 5 has increased by 70 percent in the city of Philadelphia, according to research from a University of Pennsylvania School of Nursing researcher who currently maintains the only US registry of diabetes in children that has collected data continuously since 1985.

23 Jan 2013

UCLA researchers identify abnormal tau proteins associated with sports-related concussions

Sports-related concussions and mild traumatic brain injuries have grabbed headlines in recent months, as the long-term damage they can cause becomes increasingly evident among both current and former athletes. The Centers for Disease Control and Prevention estimates that millions of these injuries occur each year.

23 Jan 2013

Important updates on traumatic brain injury in military personnel

Researchers are making new strides in understanding the health consequences and treatment and rehabilitation needs of combat veterans and other service members affected by traumatic brain injury (TBI).

23 Jan 2013

Cytos announces Novartis termination from NIC002 smoking cessation project

Cytos Biotechnology Ltd today announced that Novartis will discontinue the NIC002 project, which is a therapeutic vaccine candidate for the treatment of nicotine addiction.

23 Jan 2013

Keeping healthy blood cells alive could help fight leukaemia

Instead of focusing on the elimination of cancer cells, maintaining a stable population of healthy blood cells in the bone marrow could be the most effective way to fight against leukaemia.

23 Jan 2013

Smoking cessation helps prevent cancer relapse after surgery

Lung and head and neck cancer patients who smoked before surgery are more likely to relapse than those who had quit before surgery, Moffitt Cancer Center researchers say. They found that smoking-relapse prevention interventions are needed immediately after surgery to help prevent relapse.

23 Jan 2013

EBV reactivation can increase risk of heart disease

A new study could provide the link that scientists have been looking for to confirm that reactivation of a latent herpes virus is a cause of some heart problems.

23 Jan 2013

Studies identify cellular pathways involved in governing day-night pattern of circadian rhythms

UC Irvine-led studies have revealed the cellular mechanism by which circadian rhythms - also known as the body clock - modify energy metabolism and also have identified novel compounds that control this action. The findings point to potential treatments for disorders triggered by circadian rhythm dysfunction, ranging from insomnia and obesity to diabetes and cancer.

23 Jan 2013

Galectin Therapeutics' GR-MD-02 reverses diabetic nephropathy in preclinical study

Galectin Therapeutics, the leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer, today announced new preclinical data on the efficacy of anti-galectin therapy on diabetic kidney disease.

23 Jan 2013

SV Bio, Mayo Clinic partner on whole genome diagnostics and interpretation

Mayo Clinic and Silicon Valley Biosystems (SV Bio) today announced a strategic collaboration for whole genome diagnostics and interpretation at the Mayo Clinic Center for Individualized Medicine and Mayo Medical Laboratories.

23 Jan 2013

Medical Condition News

Taking antiepileptic drug valproate during pregnancy affects the IQ of children

SOPHIE project to evaluate social and economic policies’ impact on health inequalities

Amgen drug gets boost in fiscal cliff legislation

SMO and AKT1 mutations appear to drive about 15% of meningiomas

Tumor separation surgery followed by SRS is safe and effective in controlling spinal metastases

Trial to evaluate whether zolpidem reduces suicidal thinking in depressed insomniacs

GORE DrySeal Sheath with hydrophilic coating now available in Europe

HBR Lab offers free treatment for individuals with both weight and chronic pain

GeneDiagnostics, WILEX partner to commercialize serum HER-2/neu ELISA test in China

Covidien’s EverFlex stent with Entrust delivery system receives CE Mark

Study finds 70% increase in type 1 diabetes among very young Philadelphian children

UCLA researchers identify abnormal tau proteins associated with sports-related concussions

Important updates on traumatic brain injury in military personnel

Cytos announces Novartis termination from NIC002 smoking cessation project

Keeping healthy blood cells alive could help fight leukaemia

Smoking cessation helps prevent cancer relapse after surgery

EBV reactivation can increase risk of heart disease

Studies identify cellular pathways involved in governing day-night pattern of circadian rhythms

Galectin Therapeutics' GR-MD-02 reverses diabetic nephropathy in preclinical study

SV Bio, Mayo Clinic partner on whole genome diagnostics and interpretation

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Latest News